cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse - PubMed (original) (raw)
. 1999 Apr 15;57(2):227-34.
doi: 10.1006/geno.1999.5785.
Affiliations
- PMID: 10198162
- DOI: 10.1006/geno.1999.5785
cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse
T Oki et al. Genomics. 1999.
Abstract
We subcloned human and mouse full-length cDNAs of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT), which was designated GFAT2 (the previously reported GFAT was named GFAT1). Both the human and the mouse GFAT2 proteins deduced from their open reading frame sequences are composed of 682 amino acids of approximately 77.0 kDa. At the amino acid level, homologies between the human GFAT1 and GFAT2, between the mouse GFAT1 and GFAT2, and between the human GFAT2 and the mouse GFAT2 were 75.6, 74.7, and 97. 2%, respectively. Northern blot analysis using probe specific to human GFAT1 or GFAT2 showed that major transcripts were approximately 3.0 kb in both the human GFAT subtypes. The analysis also revealed different tissue distribution between GFAT1 and GFAT2: GFAT1 was more highly expressed in the placenta, pancreas, and testis than GFAT2; GFAT2 was expressed throughout the central nervous system, especially in the spinal cord, but GFAT1 expression was weak. The locus was mapped to human chromosome 5q and mouse chromosome 11, where a synteny between the two species has been known. GFAT2 can provide insights into understanding the roles of the hexosamine pathway in various tissues, particularly with the development of glucose toxicity and diabetes complications.
Copyright 1999 Academic Press.
Similar articles
- Identification of GFAT1-L, a novel splice variant of human glutamine: fructose-6-phosphate amidotransferase (GFAT1) that is expressed abundantly in skeletal muscle.
Niimi M, Ogawara T, Yamashita T, Yamamoto Y, Ueyama A, Kambe T, Okamoto T, Ban T, Tamanoi H, Ozaki K, Fujiwara T, Fukui H, Takahashi EI, Kyushiki H, Tanigami A. Niimi M, et al. J Hum Genet. 2001;46(10):566-71. doi: 10.1007/s100380170022. J Hum Genet. 2001. PMID: 11587069 - Phosphorylation of mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) by cAMP-dependent protein kinase increases the enzyme activity.
Hu Y, Riesland L, Paterson AJ, Kudlow JE. Hu Y, et al. J Biol Chem. 2004 Jul 16;279(29):29988-93. doi: 10.1074/jbc.M401547200. Epub 2004 May 7. J Biol Chem. 2004. PMID: 15133036 - A novel variant of glutamine: fructose-6-phosphate amidotransferase-1 (GFAT1) mRNA is selectively expressed in striated muscle.
DeHaven JE, Robinson KA, Nelson BA, Buse MG. DeHaven JE, et al. Diabetes. 2001 Nov;50(11):2419-24. doi: 10.2337/diabetes.50.11.2419. Diabetes. 2001. PMID: 11679416 - Cloning and characterization of human and mouse mitochondrial elongation factor G, GFM and Gfm, and mapping of GFM to human chromosome 3q25.1-q26.2.
Gao J, Yu L, Zhang P, Jiang J, Chen J, Peng J, Wei Y, Zhao S. Gao J, et al. Genomics. 2001 May 15;74(1):109-14. doi: 10.1006/geno.2001.6536. Genomics. 2001. PMID: 11374907 - [Molecular cloning for testis spermatogenesis cell apoptosis related gene TSARG1 and Mtsarg1 and expression analysis for Mtsarg1 gene].
Fu JJ, Lu GX, Li LY, Liu G, Xing XW, Liu SF. Fu JJ, et al. Yi Chuan Xue Bao. 2003 Jan;30(1):25-9. Yi Chuan Xue Bao. 2003. PMID: 12812072 Chinese.
Cited by
- Protein O-linked β-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function.
Darley-Usmar VM, Ball LE, Chatham JC. Darley-Usmar VM, et al. J Mol Cell Cardiol. 2012 Mar;52(3):538-49. doi: 10.1016/j.yjmcc.2011.08.009. Epub 2011 Aug 22. J Mol Cell Cardiol. 2012. PMID: 21878340 Free PMC article. Review. - O-GlcNAcylation mediates Wnt-stimulated bone formation by rewiring aerobic glycolysis.
You C, Shen F, Yang P, Cui J, Ren Q, Liu M, Hu Y, Li B, Ye L, Shi Y. You C, et al. EMBO Rep. 2024 Oct;25(10):4465-4487. doi: 10.1038/s44319-024-00237-z. Epub 2024 Sep 10. EMBO Rep. 2024. PMID: 39256595 Free PMC article. - O-GlcNAcylation: cellular physiology and therapeutic target for human diseases.
Ye L, Ding W, Xiao D, Jia Y, Zhao Z, Ao X, Wang J. Ye L, et al. MedComm (2020). 2023 Dec 19;4(6):e456. doi: 10.1002/mco2.456. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38116061 Free PMC article. Review. - Characterization of Gfat1 (zeppelin) and Gfat2, Essential Paralogous Genes Which Encode the Enzymes That Catalyze the Rate-Limiting Step in the Hexosamine Biosynthetic Pathway in Drosophila melanogaster.
Cotsworth S, Jackson CJ, Hallson G, Fitzpatrick KA, Syrzycka M, Coulthard AB, Bejsovec A, Marchetti M, Pimpinelli S, Wang SJH, Camfield RG, Verheyen EM, Sinclair DA, Honda BM, Hilliker AJ. Cotsworth S, et al. Cells. 2022 Jan 27;11(3):448. doi: 10.3390/cells11030448. Cells. 2022. PMID: 35159258 Free PMC article. - Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells.
Chen W, Do KC, Saxton B, Leng S, Filipczak P, Tessema M, Belinsky SA, Lin Y. Chen W, et al. Mol Carcinog. 2019 Jun;58(6):1046-1055. doi: 10.1002/mc.22992. Epub 2019 Mar 6. Mol Carcinog. 2019. PMID: 30790354 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous